DNA prime‐protein boost vaccine encoding HLA‐A2, HLA‐A24 and HLA‐DR1 restricted epitopes of CaNA2 against visceral leishmaniasis

Visceral leishmaniasis is a tropical and neglected disease with an estimated 200 000–400 000 cases and 60 000 deaths worldwide each year. Currently, no clinically valid vaccine is available for this disease. In this study, we formulated DNA and protein vaccines encoding HLA‐A2, HLA‐A24 and HLA‐DR1 r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Immunology
Main Authors: He, Jinlei, Huang, Fan, Zhang, Jianhui, Chen, Han, Chen, Qiwei, Zhang, Junrong, Li, Jiao, Zheng, Zhiwan, Chen, Dali, Chen, Jianping
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283657/
https://ncbi.nlm.nih.gov/pubmed/30285279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados